Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:905 (26 April), doi:10.1136/bmj.39556.400370.80
| The first 150 words of the full text of this article appear below. |
The Liverpool care pathway (LCP) is the UKs main clinical pathway of continuous deep sedation and is promoted for roll out across the NHS.1 Rietjens et als study highlights some serious weaknesses in its design.2
The eligibility criteria do not ensure that only people who are about to die are allowed on to the pathway. They allow people who are thought to be dying, are bed bound, and are unable to take tablets on to the pathway. In chronic diseases such as dementia, dying can take years, but such patients may be eligible. Reitjens et als paper shows that GPs often put patients on to such a pathway without palliative care advice. A pathway for general use should minimise opportunities for early or inappropriate use.
Murray et al are concerned that sedation is being used as an inexpensive alternative to assessment and specialist treatment.3 The LCP recommends sedatives and opiates
Adrian J Treloar, consultant and senior lecturer in old age psychiatry
1 Memorial Hospital, London SE18 3RZ
adrian.treloar@oxleas.nhs.uk
Read all Rapid Responses